
A Setback for NHS Access – But Re:Cognition Health Offers Hope for Alzheimer’s
Turning Setback Into Progress This week’s decision by NICE (the National Institute for Health and Care Excellence) to reject funding for two groundbreaking Alzheimer’s drugs Leqembi™ (lecanemab) […]